These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


421 related items for PubMed ID: 17456567

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Frequent TSH receptor genetic alterations with variable signaling impairment in a large series of children with nonautoimmune isolated hyperthyrotropinemia.
    Calebiro D, Gelmini G, Cordella D, Bonomi M, Winkler F, Biebermann H, de Marco A, Marelli F, Libri DV, Antonica F, Vigone MC, Cappa M, Mian C, Sartorio A, Beck-Peccoz P, Radetti G, Weber G, Persani L.
    J Clin Endocrinol Metab; 2012 Jan; 97(1):E156-60. PubMed ID: 22049173
    [Abstract] [Full Text] [Related]

  • 3. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3',5'-cyclic adenosine monophosphate signal generation.
    Kosugi S, Okajima F, Ban T, Hidaka A, Shenker A, Kohn LD.
    Mol Endocrinol; 1993 Aug; 7(8):1009-20. PubMed ID: 7901757
    [Abstract] [Full Text] [Related]

  • 4. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S, Krohn K, Chey S, Paschke R.
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [Abstract] [Full Text] [Related]

  • 5. Role of the cyclic adenosine 3',5'-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices.
    Corvilain B, Laurent E, Lecomte M, Vansande J, Dumont JE.
    J Clin Endocrinol Metab; 1994 Jul; 79(1):152-9. PubMed ID: 8027219
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. A family with congenital hypothyroidism caused by a combination of loss-of-function mutations in the thyrotropin receptor and adenylate cyclase-stimulating G alpha-protein subunit genes.
    Lado-Abeal J, Castro-Piedras I, Palos-Paz F, Labarta-Aizpún JI, Albero-Gamboa R.
    Thyroid; 2011 Feb; 21(2):103-9. PubMed ID: 21186955
    [Abstract] [Full Text] [Related]

  • 8. Loss-of-function mutations in the thyrotropin receptor gene as a major determinant of hyperthyrotropinemia in a consanguineous community.
    Tenenbaum-Rakover Y, Grasberger H, Mamanasiri S, Ringkananont U, Montanelli L, Barkoff MS, Dahood AM, Refetoff S.
    J Clin Endocrinol Metab; 2009 May; 94(5):1706-12. PubMed ID: 19240155
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Intracellular entrapment of wild-type TSH receptor by oligomerization with mutants linked to dominant TSH resistance.
    Calebiro D, de Filippis T, Lucchi S, Covino C, Panigone S, Beck-Peccoz P, Dunlap D, Persani L.
    Hum Mol Genet; 2005 Oct 15; 14(20):2991-3002. PubMed ID: 16135555
    [Abstract] [Full Text] [Related]

  • 11. Identification and functional characterization of two novel activating thyrotropin receptor mutants in toxic thyroid follicular adenomas.
    Castro I, Lima L, Seoane R, Lado-Abeal J.
    Thyroid; 2009 Jun 15; 19(6):645-9. PubMed ID: 19499991
    [Abstract] [Full Text] [Related]

  • 12. Expression of G(alpha)(s) proteins and TSH receptor signalling in hyperfunctioning thyroid nodules with TSH receptor mutations.
    Holzapfel HP, Bergner B, Wonerow P, Paschke R.
    Eur J Endocrinol; 2002 Jul 15; 147(1):109-16. PubMed ID: 12088927
    [Abstract] [Full Text] [Related]

  • 13. Comparative proteomic analysis to dissect differences in signal transduction in activating TSH receptor mutations in the thyroid.
    Krause K, Boisnard A, Ihling C, Ludgate M, Eszlinger M, Krohn K, Sinz A, Fuhrer D.
    Int J Biochem Cell Biol; 2012 Feb 15; 44(2):290-301. PubMed ID: 22074661
    [Abstract] [Full Text] [Related]

  • 14. Receptor cross-talk can optimize assays for autoantibodies to the thyrotropin receptor: effect of phenylisopropyladenosine on adenosine 3',5'-monophosphate and inositol phosphate levels in rat FRTL-5 thyroid cells.
    Hidaka A, Okajima F, Ban T, Kosugi S, Kondo Y, Kohn LD.
    J Clin Endocrinol Metab; 1993 Nov 15; 77(5):1164-9. PubMed ID: 8077307
    [Abstract] [Full Text] [Related]

  • 15. Identification of TSH receptor mutations in three families with resistance to TSH.
    Tonacchera M, Di Cosmo C, De Marco G, Agretti P, Banco M, Perri A, Gianetti E, Montanelli L, Vitti P, Pinchera A.
    Clin Endocrinol (Oxf); 2007 Nov 15; 67(5):712-8. PubMed ID: 17697008
    [Abstract] [Full Text] [Related]

  • 16. Thyrotropin, like luteinizing hormone (LH) and chorionic gonadotropin (CG), increases cAMP and inositol phosphate levels in cells with recombinant human LH/CG receptor.
    Hidaka A, Minegishi T, Kohn LD.
    Biochem Biophys Res Commun; 1993 Oct 15; 196(1):187-95. PubMed ID: 8216292
    [Abstract] [Full Text] [Related]

  • 17. Suppression of thyrotropin receptor-G protein-phospholipase C coupling by activation of protein kinase C in thyroid carcinoma cells.
    Broecker M, Mayr GW, Derwahl M.
    Endocrinology; 1997 Sep 15; 138(9):3787-96. PubMed ID: 9275066
    [Abstract] [Full Text] [Related]

  • 18. Functional characteristics of three new germline mutations of the thyrotropin receptor gene causing autosomal dominant toxic thyroid hyperplasia.
    Tonacchera M, Van Sande J, Cetani F, Swillens S, Schvartz C, Winiszewski P, Portmann L, Dumont JE, Vassart G, Parma J.
    J Clin Endocrinol Metab; 1996 Feb 15; 81(2):547-54. PubMed ID: 8636266
    [Abstract] [Full Text] [Related]

  • 19. Proper targeting and activity of a nonfunctioning thyroid-stimulating hormone receptor (TSHr) combining an inactivating and activating TSHr mutation in one receptor.
    Agretti P, De Marco G, Collecchi P, Chiovato L, Vitti P, Pinchera A, Tonacchera M.
    Eur J Biochem; 2003 Sep 15; 270(18):3839-47. PubMed ID: 12950268
    [Abstract] [Full Text] [Related]

  • 20. Low prevalence of thyrotropin receptor mutations in a large series of subjects with sporadic and familial nonautoimmune subclinical hypothyroidism.
    Tonacchera M, Perri A, De Marco G, Agretti P, Banco ME, Di Cosmo C, Grasso L, Vitti P, Chiovato L, Pinchera A.
    J Clin Endocrinol Metab; 2004 Nov 15; 89(11):5787-93. PubMed ID: 15531543
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.